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a b s t r a c t
Background and purpose: The signiﬁcance of segmental heart wall motion abnormalities for
stroke is unknown. The aims of the study included (1) comparison of the frequency and type
of embolic signals in the middle cerebral artery in patients with segmental left ventricular
wall hypokinesis due to coronary heart disease with and without stroke, and (2) determina-
tion of the relationship between inﬂammatory parameters, ﬁbrinogen level, dyslipidemia
and microembolic signals in the middle cerebral artery in patients with segmental heart
hypokinesis.
Material and methods: The study included 68 patients with segmental heart hypokinesis (33
without stroke [group I] and 35 with stroke [group II]), as well as 37 healthy volunteers and a
reference group of 30 patients. Echocardiography and carotid/transcranial Doppler with
detection of microembolic signals were performed. Patients from group I and II had
erythrocyte sedimentation rate, leucocyte count, triglycerides, total cholesterol, HDL, and
LDL examined.
Results: Embolic signals were detected in patients with segmental heart hypokinesis signiﬁ-
cantly more frequently than in the control and reference groups. The high number of
embolic signals, signals of high intensity, hypokinesis of the distal part of the intraventricu-
lar septum, increased cholesterol levels, LDL and triglycerides were all found more frequent-
ly in patients from group II than in group I. Embolic signals were detected more frequently in
patients with high ﬁbrinogen levels and leukocytosis.
Conclusions: Embolic signals in the middle cerebral artery in patients with segmental left
ventricular hypokinesis have to be considered as a risk factor of stroke. The following
changes are observed in patients with cardiogenic stroke: hypokinetic intraventricular
septum, high intensity embolic signals, increased serum ﬁbrinogen levels and leucocyte
count. It may indicate the importance of these factors in the aetiology of stroke.
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Cerebral artery embolisms of cardiac origin are a clinically
signiﬁcant source of strokes. According to Warlow, they
constitute the cause of 20% of cerebral infarctions. Thrombi
developing in the heart are the embolic material in these cases
[1]. According to Welch et al. [2], the causes of the absolute risk
of cardiogenic cerebral embolism include: atrial ﬁbrillation,
mitral stenosis, mechanical heart valves, early myocardial
infarction, atrial myxoma and the presence of thrombus in the
left ventricle. The relative causes include, among other things,
mitral valve prolapse, patent foramen ovale, interatrial septal
aneurysm, calciﬁc aortic stenosis and segmental left ventric-
ular wall motion abnormalities post myocardial infarction [3].
The level of risk of cardiogenic stroke is still a controversial
issue in such cases.
Literature data suggest a relationship between global left
ventricular systolic function impairment in the form of a
decrease in cardiac ejection fraction and the formation of
cardiogenic embolism. Advanced systolic function impairment
contributes to the formation of thrombus in the left ventricle. It
is also assumed that the presence of hypokinetic segments in
the cardiac wall may be conducive to the formation of thrombi
[4]. The introduction and modiﬁcation of methods of detecting
embolic material (echocardiography and transcranial Doppler
examination with embolism monitoring) over the past three
decades are an argument in favour of revising the opinion on the
risk of cerebral embolism secondary to various cardiac diseases.
In the literature, it is accepted that there is a relationship
between the presence of emboli and the occurrence of
clinically evident stroke [5–10]. So far, a number of reports
on monitoring embolism in diseases constituting its potential
cause have been published. Publications regarding the
assessment of embolism in diseases considered to be relative
causes of cardiogenic cerebral embolism are scarce. The
combination of echocardiography and transcranial Doppler
examination seems to be an optimal method in determining
the signiﬁcance of segmental left ventricular wall motion
abnormalities for the occurrence of cardiogenic cerebral
embolism.
The aims of the study included (1) comparison of the
frequency and type of microembolic signals detected in the
middle cerebral artery on transcranial Doppler ultrasonogra-
phy in patients with segmental left ventricular wall motion
abnormalities secondary to ischaemic heart disease without
stroke and with cardiogenic stroke; and (2) determining
relationships between selected indicators of inﬂammation
(erythrocyte sedimentation rate [ESR], leucocyte count),
ﬁbrinogen levels as well as lipid disorders and the presence
of microembolic signals in the middle cerebral artery on
transcranial Doppler ultrasonography in patients with seg-
mental left ventricular wall motion abnormalities.
2. Material and methods
Sixty-eight patients hospitalized at the 2nd Cardiology
Department of the Medical University of Silesia or the
Neurology Department of the Medical University of Silesiabetween 1999 and 2010 in whom segmental left ventricular
wall motion abnormalities were found with the use of
transthoracic echocardiography (TTE) were examined.
The subjects were divided into two groups. Group I consisted
of 33 patients (9 women and 24 men) aged 21–71 years (mean:
53.7; standard deviation [SD]: 10.85 years) with ischaemic heart
disease diagnosed by a cardiologist (on the basis of anginal pain
in patient history and the signs of past ischemia in electrocar-
diogram [ECG]), without the clinical signs of stroke. Group II
included 35 patients (9 women and 26 men) aged 37–87 years
(mean: 62.7; SD: 12.6 years) with ischemic disease who were in
the acute phase of embolic ischaemic stroke during the study.
Cardiogenic stroke was diagnosed on the basis of ischaemic
stroke classiﬁcation criteria proposed by Adams et al. [11]. The
study did not include patients with past stroke, another
concomitant or past central nervous system (CNS) disease,
valvular heart disease and implanted valves, cardiac dysrhyth-
mias, thrombus present in the heart, myocardial infarction in
the past 6 months as well as stenosis or occlusion of carotid and
intracranial arteries diagnosed on the basis of the results of a
Doppler examination.
The types of left ventricular systolic function impairment
and their prevalence are presented in Table 1.
The following diseases co-occurred in the subjects: arterial
hypertension in 40 patients: 17 from group I (51.5%) and 23
from group II (65.7%) (non-signiﬁcant, NS); type 2 diabetes in 22
subjects: nine from group I (27.3%) and 13 from group II (37.1%)
(NS); lipid disorders in 23 subjects: one from group I (3.03%) and
22 from group II (62.8%) ( p < 0.001).
The reference group consisted of 30 patients treated at the
Cardiology and Diabetology Outpatient Clinic of the Indepen-
dent Teaching Hospital No. 7 in Katowice (20 women and 10
men) aged 38–74 years (mean: 56.5 years; SD: 9.7) without left
ventricular function impairment (normal results of TTE), in
whom the main risk factors for atherosclerosis (arterial
hypertension, hyperlipidaemia and diabetes), similar to those
in groups I and II, occurred: Arterial hypertension occurred in
10 subjects (33.3%), type 2 diabetes in 23 subjects (76.7%), and
lipid disorders in 28 subjects (93.3%). Ischaemic heart disease
was found in 6 patients.
The control group consisted of 37 healthy volunteers (23
women and 14 men) aged 41 to 71 years (mean: 54.1 years; SD:
8.98), who were patients with radicular syndromes treated at
the Neurology Department and Neurology Outpatient Clinic.
Physical and neurological examinations along with recent
laboratory test results allowed us to exclude cardiovascular
and central nervous system diseases in them.
All patients from groups I and II as well as the reference and
control ones were informed of the objective of the study and
consented to it. The study was approved by the Bioethical
Commission of the Medical University of Silesia.
The following measures were carried out in the patients
with segmental left ventricular wall motion abnormalities
(groups I and II) and in the reference group: (1) Interview and
physical examination; (2) TTE and, additionally in 11 patients
in whom TTE did not allow an unequivocal exclusion of the
presence of thrombus, transesophageal echocardiography
(TEE) was performed; and (3) 12-lead ECG.
The following were additionally performed in groups I and
II: ESR and leucocyte count, total cholesterol, triglycerides, HDL
Table 1 – Types of left ventricular wall motion abnormalities in groups I and II.
Type of left ventricular systolic
function impairment
Patients with systolic
function impairment
Group I n = 33 Group II n = 35 p-Value
n % n %
Hypokinesis of whole IVS 10 4 12.1 6 17.1 NS
Hypokinesis of distal part of IVS 18 14 42.4 4 11.4 0.0061
Asynchronism of IVS contraction 2 2 6.1 0 0 NS
Hypokinesis of anterior wall 2 0 0 2 5.7 NS
Hypokinesis of side wall 17 5 15.1 12 34.3 NS
Hypokinesis of apex 16 7 21.2 9 25.7 NS
Hypokinesis of inferior wall 3 1 3.03 2 5.7 NS
IVS – intraventricular septum; NS – not signiﬁcant.
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included patients underwent examination of blood ﬂow
velocity in extra- and intracranial blood vessels, in the middle
cerebral artery with the Doppler method – patients with
ischaemic stroke in the ﬁrst 24–48 h of the disease, patients
without the signs of stroke during their stay at hospital, and in
the reference and control groups on an outpatient basis.
Detection of cerebral embolism in the middle cerebral
artery (at the depth of 60 mm for 30 min on each side) was
performed in patients with ischaemic stroke in the ﬁrst 24–
48 h of the disease, in patients without the signs of stroke
during their stay at the hospital and in the reference and
control groups on an outpatient basis. The total number of
microembolic signals per hour and the intensity of the
microembolic signals were determined in each patient. In
the study, we use the term 'signal intensity', frequently
utilized in English-language literature, which is equivalent to
the term ‘‘signal frequency’’ expressed in decibels. Microem-
bolic signals were analyzed with the use of commercially
available software developed by EME. Doppler examinations
and detection of cerebral embolism were performed at the
Doppler Laboratory of the Neurology Department of the
Independent Public Teaching Hospital No. 7 in Katowice. A
Pioneer 2002 TC device, manufactured by EME, equipped with
2- and 4-MHz transducers as well as a two-gate transducer for
detecting cerebral embolism was used. The detected micro-
embolic signals met the Spencer criteria [12].
2.1. Statistical analysis
Statistical analysis was carried out with the use of licensed
versions of: Microsoft Excel 2003 and Statsoft Statistica 7.1 PL
software. At the ﬁrst stage of the statistical analysis, the basic
descriptive statistics were determined (arithmetic means,Table 2 – Number of persons with the presence of 1, 2 or 3 mi
Number of
patients with MES
Patient
1 MES 2 MES 
n (%) n (%) 
Group I (n = 33) 10 4 (12.1%) 6 (18.2%) 
Group II (n = 35) 17 2 (5.7%) 9 (25.7%) 
a Fisher test.medians, quartiles, variances, standard deviations, etc.). The
x2 test for independence or Fisher exact test was used to
compare the distribution of nonparametric variables. Non-
parametric variables were compared with the use of Student
t-test (age – normal distribution) or the Mann–Whitney U-test
(the duration of coronary heart disease not meeting the
condition of normal distribution). The null hypothesis con-
cerning the conformity of a given parameter to normal
distribution was assessed with the use of the Kolmogorov–
Smirnov or Shapiro–Wilk tests. In the statistical analysis, the
accepted level of statistical signiﬁcance (type I error) was p
(a) < 0.05.
3. Results
Microembolic signals were detected in 10 patients in group I, 17
patients in group II and in one individual in the reference
group. They were not found in individuals in the control group.
The difference between groups I and II was statistically
insigniﬁcant. Statistical signiﬁcance was achieved when
comparing results obtained in patients with segmental left
ventricular wall motion abnormalities (groups I and II) with
that of the control group ( p < 0.01) as well as the reference
group ( p < 0.01).
Larger numbers of microembolic signals (3–7 signals) were
found in patients in group II. The statistical difference was
signiﬁcant in comparison with patients from group I ( p < 0.05)
(Table 2).
Higher-intensity microembolic signals (7–11 dB) were found
in patients in group II. The statistical difference was signiﬁcant
in comparison with patients from group I ( p < 0.01) (Table 3).
Microembolic signals in group II, i.e. in patients with stroke,
were recorded more frequently in comparison with group Icroembolic signals (MES) recorded in groups I and II.
s with: No of patients
with 1–2 MES
No of patients
with 3–7 MES
3 MES 7 MES p = 0.047a
n (%) n (%)
10 0
5 (14.3%) 1 (2.9%) 11 6
Table 3 – The frequency of the signals of different intensities in groups I and II.
Patients with MES of different intensities n (%) Number of
patients with
MES
5 dB 6 dB 7 dB 8 dB 9 dB 10 dB 11 dB 5–6 dB 7–11 dB
Group I (n = 33) 9 (27%) 1 (3%) 10 0 p < 0.01
Group II (n = 35) 8 (22.8%) 8 (22.8%) 4 (11.4%) 2 (5.7%) 1 (2.8%) 1 (2.8%) 1 (2.8%) 16 9
MES – microembolic signals.
Table 4 – The frequency of microembolic signals (MES) in groups I and II, depending on the location of segmental left
ventricular wall motion abnormalities.
Localization of left
ventricular impairment
No of patients
Group I + II n = 68 Group I n = 33 Group II n = 35 p-Value
All
patients
Patients
with MES
All
patients
Patients
with MES
All patients Patients
with MES
Hypokinesis of whole IVS 10 7 (70%) 4 4 (100%) 6 3 (50%) NS
Hypokinesis of distal part of IVS 18 6 (33.3%) 14 3 (21.4%) 4 3 (75%) <0.05
Asynchronism of IVS contraction 2 1 (50%) 2 1 (50%) 0 0 NS
Hypokinesis of side wall 17 5 (24.9%) 5 0 12 5 (41.6%) NS
Hypokinesis of anterior wall 2 0 0 0 2 0 NS
Hypokinesis of inferior wall 3 1 (33.3%) 1 0 2 1 (50%) NS
Hypokinesis of apex 16 7 (43.7%) 7 2 (28.6%) 9 5 (55.5%) NS
IVS – intraventricular septum; NS – not signiﬁcant.
Table 5 – Selected inflammatory and lipid variables in groups I and II.
Variable Range Group I Group II p
n % n %
ESR 5/10 mm/h 22 66.6 16 45.7 NS
>5/10 mm/h 11 33.3 19 54.3
WBC 10  103/mL 27 81.8 28 80 NS
>10  103/mL 6 18.2 7 20
Cholesterol 200 mg/dL 32 96.9 19 54.3 <0.001
>200 mg/dL 1 3.03 16 45.7
Triglycerides 150 mg/dL 33 100 23 65.7 <0.05
>150 mg/dL 0 0 12 34.3
LDL-cholesterol 100 mg/dL 33 100 22 62.8 <0.001
>100 mg/dL 0 0 13 37.1
HDL-cholesterol >40 mg/dL 33 100 34 97.1 NS
40 mg/dL 0 0 1 2.8
Fibrinogen 3.5 g/L 30 90.9 27 77.1 NS
>3.5 g/L 3 9.1 8 22.9
ESR – erythrocyte sedimentation rate; WBC – white blood cell; GR – group; NS – not signiﬁcant.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 9 8 – 1 0 4 101only in the cases of hypokinesis located in the distal part of the
interventricular septum ( p < 0.05) (Table 4).
Elevated total cholesterol (>200 mg/dL), LDL (>100 mg/dL),
and triglycerides (>150 mg/dL) levels were found signiﬁcantly
more frequently in group II in comparison with group I
(Table 5).
Among patients with segmental left ventricular wall
motion abnormalities (groups I and II), microembolic signals
occurred signiﬁcantly more frequently in patients with
elevated ﬁbrinogen levels (>3.5 g/L) and in patients with
elevated leucocyte count (>10  103/mL) in comparison
with patients with normal ﬁbrinogen levels and leucocyte
counts ( p < 0.001 and p < 0.02, respectively). No statisticallysigniﬁcant differences between patients with normal and
abnormal parameters: ESR, total cholesterol, LDL, HDL,
triglycerides levels as well as ejection fraction (<40% vs.
>40%) were observed (Table 6).
4. Discussion
The objective of the study was to determine, by monitoring
embolisms with the use of TCD, whether the presence of
segmental left ventricular wall motion abnormalities can be
the source of embolic material. Patients with cerebrovascular
disease had microembolic signals more often than patients
Table 6 – The presence of microembolic signals (MES) and the results of selected laboratory tests for the whole group of 68
patients with segmental left ventricular dysfunction.
Variable Range No of patients MES p-Value
n %
ESR 5/10 mm/h 38 12 31.6 NS
>5/10 mm/h 30 15 50
WBC 10  103/mL 55 18 32.7 <0.02
>10  103/mL 13 9 69.2
Total cholesterol 200 mg/dL 51 19 37.2 NS
>200 mg/dL 17 8 47.1
Triglycerides 150 mg/dL 56 22 39.3 NS
>150 mg/dL 12 5 41.6
LDL-cholesterol 100 mg/dL 55 21 38.2 NS
>100 mg/dL 13 6 46.1
HDL-cholesterol >40 mg/dL 67 26 38.8 NS
40 mg/dL 1 1 100
Fibrinogen 3.5 g/L 57 17 29.8 <0.001
>3.5 g/L 11 10 90.9
Left ventricle ejection fraction 40% 64 26 40.6 NS
<40% 4 1 25
ESR – erythrocyte sedimentation rate; WBC – white blood cell; NS – not signiﬁcant.
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reports by Babikian et al. [14], Markus et al. [15] and Kumral
et al. [16]. In the presented study, in the group of patients with
segmental left ventricular wall motion abnormalities without
the clinical symptoms of stroke, microembolic signals were
detected in almost 1/3 of patients. Similar results were
obtained by Sliwka et al. [17] and Tong et al. [18]. The
difference in the incidence of microembolic signals between
groups I and II was statistically insigniﬁcant in the presented
study. They occurred, however, signiﬁcantly more often in
patients with segmental left ventricular wall motion abnor-
malities (groups I and II) in comparison with the control and
reference groups. The obtained results, therefore, conﬁrm the
hypothesis that segmental left ventricular wall motion
abnormalities are associated with the presence of microem-
bolic signals.
The incidence of microembolic signals in patients with
segmental left ventricular wall motion abnormalities in
whom no other possible causes of cardiogenic embolism
have been found was analyzed in the presented study. The
results of the presented study suggest that embolism can also
be found when only segmental left ventricular wall motion
abnormalities without a simultaneously detectable thrombus
are detected in a patient. The frequency of detection of
microembolic signals in these cases is similar to the results
obtained by Kuznetsow et al. [19] in patients with cardiogenic
ischaemic stroke with one cause of cardiogenic cerebral
embolism.
More microembolic signals are detected in patients with
stroke and a cardiac cause of embolism than in patients with
stroke without a determined potential source of embolism
[20,21]. The number of signals increases in cardiac diseases
associated with a higher risk of the occurrence of embolism
[22,23]. The presented results are comparable with those
obtained by other authors and suggest that the number of
microembolic signals increasing to at least 3 in patients with
segmental left ventricular wall motion abnormalities shouldbecome a signal warning against the possibility of the
occurrence of ischaemic embolic stroke [24].
The analysis of the intensity of microembolic signals in the
study groups allowed us to determine that only low-intensity
signals were detected in patients without stroke. In turn, in the
group of patients with stroke, higher-intensity microembolic
signals occurred as well. It has been proven that the higher
intensity of microembolic signals is dependent on the density
of embolism more than on its size [22]. In the literature, it has
been demonstrated that solid emboli consisting of various
platelet aggregates cause weaker (lower intensity) microem-
bolic signals than atherosclerotic particles of the same size
[25]. The cardiogenic causes of embolism are the source of
signals of both higher and lower intensity [26]. These
differences can be associated with the heterogeneity of
cardiogenic embolic material. The results of the presented
study suggest that patients with conﬁrmed presence of
segmental left ventricular wall motion abnormalities and
the presence of high-intensity microembolic signals are at a
particularly high risk of clinically evident stroke.
Periapical left ventricular wall motion abnormalities found
with the use of TTE are important factors predisposing the
formation of left ventricular thrombus [27,28]. The results of
the presented study concerning patients without fresh
myocardial infarction and only with segmental wall motion
abnormalities conﬁrm these observations. In the group of
patients without an ischaemic cerebral event, segmental left
ventricular wall motion abnormalities were associated with
the occurrence of microembolic signals only in cases with
apical hypokinesis. In the group of patients post-ischaemic
stroke more than a half of patients with apical hypokinesis
also had microembolic signals on TCD, i.e. more frequently
than with another location of segmental left ventricular wall
motion abnormalities. This result seems to be in agreement
with the opinion, suggested in the newest reports, that the
basic factors increasing the risk of cardiogenic embolic
complications include the location of the formation of embolic
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characteristics of microembolic signals [22]. According to the
results of the presented study, the distal part of the septum
seems to be a place of easier formation of dangerous embolic
material as well. The occurrence of microembolic signals in
patients with stroke was signiﬁcantly more common in
comparison with individuals without stroke in cases of
hypokinesis located in the distal part of the interventricular
septum.
The causal relationship between hypercholesterolaemia
and stroke is not so well documented as in the case of
coronary artery disease. It is doubtless that there is a direct
relationship between hyperlipidemia and carotid artery
atherosclerosis, which is currently a sufﬁcient argument in
favour of considering hyperlipidemia to be a risk factor for
ischaemic stroke. In the discussed study, occurrence of
elevated total cholesterol, LDL and triglycerides as well as
decreased HDL levels was found more frequently in patients
with the symptoms of acute stroke in comparison with group
I. However, the elevated lipid metabolism parameters did not
exhibit a relationship with the occurrence of microembolic
signals. It is worth mentioning that platelets are considered to
be the main cellular element of particles generating micro-
embolic signals. It has been proven that the platelets of
patients in the acute phase of ischaemic stroke are activated
[29]. However, it is still unknown if platelet activation is an
independent risk factor or a result of the impact of
hyperlipidemia, diabetes and arterial hypertension, which
affect their functions [30]. Among the potential haemostasis
disorders, only plasma ﬁbrinogen concentration has been
veriﬁed as an independent risk factor for arterial thrombosis
in prospective epidemiological studies [31–33]. A summary
report concerning 7 studies conﬁrmed that plasma concen-
tration of ﬁbrinogen that is within the upper third of the
normal range increases the risk of cardiovascular diseases by
2.3 times in comparison with the group of individuals in
whom such concentration was in the lower third of the
normal range [34]. This risk is particularly increased by the co-
occurrence of arterial hypertension. Increases in ﬁbrinogen
levels and blood viscosity are more signiﬁcant for prognosis
than hypercholesterolaemia. High ﬁbrinogen concentration
worsens prognosis in patients after ischaemic stroke [35]. In
the presented study, elevated ﬁbrinogen concentration was
signiﬁcantly associated with the occurrence of microembolic
signals, which seems to suggest the importance of elevated
ﬁbrinogen concentration for the formation of emboli. Leuko-
cytosis was also signiﬁcantly associated with the occurrence
of embolism. Therefore, hyperﬁbrinogenaemia was perhaps –
at least in some patients – stimulated by infection and these
two factors were signiﬁcant for the formation of emboli in
these patients. In the literature, it has been demonstrated
that when several causes of thrombus formation within the
heart co-occur, its embolic potential increases [19,22].
Combined abnormalities, therefore, increase the risk of
cerebral embolism. In the presented study, in patients with
segmental left ventricular wall motion abnormalities, it was
also found that the risk of cerebral embolism depends on the
location of wall motion abnormalities, the intensity and
number of microembolic signals as well as ﬁbrinogen
concentration.5. Method limitations
The long period of patient recruitment was caused by
difﬁculties in selecting a group that would closely reﬂect the
inclusion and exclusion criteria. It was particularly difﬁcult to
ﬁnd patients with stroke in whom it was possible to assume, at
a level of probability close to certainty, that embolism was
solely caused by segmental left ventricular wall motion
abnormalities, that is, patients in whom other causes of
embolism were unequivocally excluded. In the second group,
the causes of ischaemic heart disease were not established.
Because in the general population more than 98% of its cases
are caused by coronary artery atherosclerosis, this aetiology
can be assumed at a high level of probability in the subjects
from group II as well. Throughout the entire study period, a
protocol established before its beginning (1999) was observed
and it was impossible to modify it in the following years
in spite of the increased availability of laboratory tests,
e.g. CRP.
6. Conclusions
1. Microembolic signals detected in the middle cerebral artery
with the use of Doppler ultrasonography in individuals with
segmental left ventricular wall motion abnormalities can be
clinically signiﬁcant as a risk factor for stroke.
2. Patients with cardiogenic stroke are frequently found to
have septal hypokinesis, higher-intensity microembolic
signals, elevated ﬁbrinogen concentration and an increase
in serum leucocyte count, which can suggest that the listed
factors are signiﬁcant for the aetiology of stroke.
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